Fatty Liver/NASH/MASH
Fatty Liver/NASH/MASH
Non Alcoholic Steatohepatitis (NASH) is a type of fatty liver disease, characterized by inflammation of the liver with concurrent fat accumulation in liver
NASH is closely related to the triple epidemic of obesity, pre-diabetes, and diabetes. If you are living with NASH you may qualify for a clinical research study.
MASH is the advanced stage of MASLD. MAFLD is a type of metabolic syndrome characterized by being overweight or obese, elevated blood pressure, blood lipids, and either diabetes or pre-diabetes. Researchers believe that oxidative stress, inflammatory proteins, liver cell damage, adipose tissue inflammation, and the gut microbiota may contribute to its development.
Join Encore Borland Groover Clinical Research (EBGCR) for a complimentary Fibroscan test for fatty liver.
ClinicalTrials.gov Study Details
Contact Research
4800 Belfort Road Jacksonville FL 32256
Contact Research: (904) 680-0871
Research Email: [email protected]
1679 Eagle Harbor Parkway Suite D Fleming Island FL 32003
Contact Research: (904) 621-0390
Research Email: [email protected]
Encore Borland Groover Clinical Research
4800 Belfort Road Jacksonville FL 32003
Contact Research: 904-680-0871